The Brigham and Dana-Farber Board Review in Hematology 2018
Brigham and Women’s Hospital Board Review
- Oakstone Price: $1395.
- Format: 34 Video Files (.mp4 format) + 2 PDF files.
- File Size: 6.65 GB.
- Download Link Below.
This post contains protected content. You must contact us to unlock it.
Stay Current with this Board Review in Hematology
The Brigham and Dana-Farber Board Review in Hematology CME program brings together adistinguished group of experts to present up-to-date diagnostic and therapeutic strategies. Enhance patient care and prepare for boards with topics like molecular genetics, leukemia, bone marrow failures, transfusion medicine and more. You will learn to:
- Apply current/recommended hematology guidelines in clinical practice
- Perform differential diagnosis of complex hematologic disorders
- Identify and apply current therapeutic options for hematologic disorders
- Evaluate and interpret up-to-date literature relevant to hematology
- Illustrate knowledge of pathophysiology of hematology disorders
- Apply knowledge gained to the ABIM certification/recertification
Discover New Guidelines
A clinically based update, this learn-at-your-own-pace CME course in hematology provides a maximum of 26 AMA PRA Category 1 Credits ™ and 26 MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.
Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Oakstone Publishing, LLC designates this enduring material for a maximum of 26 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn 26 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Date of Original Release: June 30, 2018
Termination Date: June 30, 2021
Upon completion of this activity, the participant will be able to:
- Apply current/recommended Hematology guidelines in clinical practice
- Perform differential diagnosis of complex Hematologic disorders
- Identify/apply current therapeutic options for Hematologic disorders
- Evaluate and interpret up-to-date literature relevant to clinical practice in Hematology
- Illustrate knowledge of pathophysiology as it applies to management of Hematology disorders
- Apply knowledge gained to the ABIM certification/recertification Hematology examinations
This course is designed to provide Hematology fellows/trainees, Hematologists/Oncologists and Internists with diagnostic and therapeutic strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty board exam in Hematology.
- Molecular Genetics of Cancer – Nikhil Wagle, MD
- Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
- Infections in Cancer Patients – Lindsey Baden, MD
- Symptom Management in Patients with Cancer – Janet L. Abrahm, MD
- Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD
- Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
- Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
- Acute Leukemias – Daniel J. DeAngelo, MD, PhD
- Myelodysplastic Syndrome – David P. Steensma, MD
- Chronic Myelogenous Leukemia – Joseph H. Antin, MD
- Myeloproliferative Syndromes – Ann M. Mullally, MD
- Multiple Myeloma – Kenneth C. Anderson, MD
- Waldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD
- Low Grade Lymphomas – Caron A. Jacobson, MD
- High Grade Lymphomas – Eric D. Jacobsen, MD
- Hodgkin’s Lymphoma – Ann S. LaCasce, MD
- Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
- Hematopoiesis and Cytokines – David T. Scadden, MD
- Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
- Congenital Bone Marrow Failure – David A. Williams, MD
- Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
- Anemia: An Overview – Ronald P. McCaffrey, MD
- Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD
- Immune Hemolytic Anemia – Richard M. Kaufman, MD
- Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
- Sickle Cell Disease – Maureen M. Achebe, MD, MPH
- Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
- Disorders of Neutrophils – Nancy Berliner, MD
- Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
- Hemophilia – Aric D. Parnes, MD
- Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
- Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
- New Oral Anticoagulants – Jean M. Connors, MD
- Transfusion Medicine for the Clinician – Walter H. Dzik, MD